JILL MCCREIGHT: Open Payments
NPI 1669851010 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 23 payments from 10 companies in 2025. Trend: 2023 $174 · 2024 $112 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $116 |
| Lilly USA, LLC | 5 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $82 |
| Dexcom, Inc. | 2 | $55 |
| PFIZER INC. | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
| Abbott Laboratories | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: JARDIANCE, Ozempic, Dexcom G6 Transmitter, NURTEC ODT, Kerendia, MOUNJARO, ZEPBOUND, Rybelsus.
Industry payments across SC — which companies pay providers there.
